Comparison of integrin α v β 3 expression with 68 Ga-NODAGA-RGD PET/CT and glucose metabolism with 18 F-FDG PET/CT in esophageal or gastroesophageal junction cancers.

Matthieu DietzVincent DunetStyliani MantziariAnastasia PomoniRicardo Dias CorreiaNathalie Testart DardelSarah BoughdadMarie Nicod LalondeGiorgio TregliaMarkus SchaferNiklaus SchaeferJohn O Prior

Published in: European journal of hybrid imaging (2023)

Trial registration: NCT02666547. Registered January 28, 2016-Retrospectively registered, https://clinicaltrials.gov/ct2/show/NCT02666547 .

Keyphrases

pet ct
positron emission tomography
poor prognosis
phase iii
study protocol
computed tomography
image quality
dual energy
clinical trial
phase ii
contrast enhanced
randomized controlled trial
binding protein
magnetic resonance imaging
long non coding rna
open label
clinical evaluation